1. Home
  2. WHG vs NKTR Comparison

WHG vs NKTR Comparison

Compare WHG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHG
  • NKTR
  • Stock Information
  • Founded
  • WHG 1983
  • NKTR 1990
  • Country
  • WHG United States
  • NKTR United States
  • Employees
  • WHG N/A
  • NKTR N/A
  • Industry
  • WHG Investment Managers
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHG Finance
  • NKTR Health Care
  • Exchange
  • WHG Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • WHG 147.1M
  • NKTR 160.4M
  • IPO Year
  • WHG 2002
  • NKTR 1994
  • Fundamental
  • Price
  • WHG $16.25
  • NKTR $0.78
  • Analyst Decision
  • WHG
  • NKTR Strong Buy
  • Analyst Count
  • WHG 0
  • NKTR 6
  • Target Price
  • WHG N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • WHG 14.2K
  • NKTR 2.8M
  • Earning Date
  • WHG 04-30-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • WHG 3.56%
  • NKTR N/A
  • EPS Growth
  • WHG N/A
  • NKTR N/A
  • EPS
  • WHG 0.26
  • NKTR N/A
  • Revenue
  • WHG $94,721,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • WHG N/A
  • NKTR N/A
  • Revenue Next Year
  • WHG N/A
  • NKTR N/A
  • P/E Ratio
  • WHG $64.46
  • NKTR N/A
  • Revenue Growth
  • WHG 5.50
  • NKTR 9.21
  • 52 Week Low
  • WHG $11.01
  • NKTR $0.43
  • 52 Week High
  • WHG $18.03
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • WHG 60.85
  • NKTR 59.90
  • Support Level
  • WHG $16.05
  • NKTR $0.43
  • Resistance Level
  • WHG $17.09
  • NKTR $0.68
  • Average True Range (ATR)
  • WHG 0.76
  • NKTR 0.07
  • MACD
  • WHG 0.14
  • NKTR 0.03
  • Stochastic Oscillator
  • WHG 90.99
  • NKTR 90.84

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high-net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: